Orchid BioSciences (Nasdaq: ORCH) said on Tuesday it has signed a definitive agreement to acquire Lifecodes, a Stamford, Connecticut-based provider of identity genomics testing for forensics and ...

Recently, Hologic Inc. (HOLX) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument–reagent systems space in the blood transfusion ...

Medical device maker Hologicannounced in a press release late last week that it agreed with diagnostics maker Immucor to sell its Lifecodes business. Lifecodes, which handles transplant diagnostics, ...

Bedford-based medical device maker Hologic Inc. said it has successfully completed the sale of its Lifecodes business unit to Immucor Inc. Hologic has received $85 million in cash with the opportunity ...

Hologic Inc. of Bedford, which has operations in Marlborough, announced the sale of its Lifecodes business to Georgia-based Immucor Inc. Hologic, which develops and manufactures medical products for ...

Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced a definitive agreement to acquire the LIFECODES business, which ...

Recently, Hologic Inc. (HOLX) inked a definitive agreement to divest its LIFECODES business unit to Immucor Inc. to focus more on its core business activities. The divestiture is expected to close ...

Bedford, Mass.-based medical imaging and diagnostic test company, Hologic Inc. (Nasdaq: HOLX) completed the sale of its LIFECODES business unit to Georgia-based Immucor, a blood transfusion technology ...

Recently, Hologic Inc. ( HOLX) completed the divestment of its LIFECODES business unit to Immucor Inc., a prominent player in the automated instrument-reagent systems space in the blood transfusion ...